Breaking News Instant updates and real-time market news.

PTGX

Protagonist Therapeutics

$12.85

0.36 (2.88%)

07:13
07/08/19
07/08
07:13
07/08/19
07:13

Protagonist Therapeutics initiated with a Buy at H.C. Wainwright

H.C. Wainwright analyst Douglas Tsao started Protagonist Therapeutics with a Buy rating and $23 price target. While Protagonist's pipeline remains relatively early stage, the Phase 2 data expected later this year for PTG-300 should be an important catalyst for shares since the data may cause investors to assign a much higher valuation to that program, especially as the company should begin work on a second indication, Tsao tells investors in a research note.

PTGX Protagonist Therapeutics
$12.85

0.36 (2.88%)

02/21/19
BMOC
02/21/19
INITIATION
BMOC
Outperform
Protagonist Therapeutics initiated with an Outperform at BMO Capital
BMO Capital analyst George Farmer initiated Protagonist Therapeutics with an Outperform rating and $17 price target. Farmer said the recent stock pullback offers an attractive entry point based on the potential of the company's "novel peptide chemistry platform," and that positive outcomes of upcoming catalysts this year could drive shares close to $17 per share.
05/08/19
STFL
05/08/19
UPGRADE
Target $17
STFL
Buy
Protagonist Therapeutics upgraded to Buy from Hold at Stifel
Stifel analyst Adam Walsh upgraded Protagonist Therapeutics to Buy from Hold and raised his price target for the shares to $17 from $11.
05/09/19
STFL
05/09/19
UPGRADE
Target $17
STFL
Buy
Stifel upgrades Protagonist Therapeutics to Buy after Janssen opts in
Stifel analyst Adam Walsh last night upgraded Protagonist Therapeutics to Buy from Hold and raised his price target for the shares to $17 from $11. The expansion of the deal between Protagonist and Janssen for PTG-200 and other IL-23 receptor antagonists brings large pharma validation to the former's oral peptide platform, Walsh tells investors in a research note. The analyst now has increased confidence in PTG-200. Janssen's decision to opt-in to further PTG-200 development is supportive of PTG-200's potential in Crohn's and should assuage investor fears around Protagonist's oral peptide technology, says the analyst.
05/09/19
05/09/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Atlassian (TEAM) upgraded to Buy from Neutral at Goldman Sachs with Heather Bellini saying consensus billings expectations for Q4 of $361M, or up 30% year-over-year, appear conservative. 2. Match Group (MTCH) upgraded to Neutral from Sell at Goldman Sachs with 3ith analyst Michael Ng stating that the positive stock reaction to Match's in-line Q1 revenue and EBITDA results illustrate the market is more focused on the longer-term investment thesis. 3. Protagonist Therapeutics (PTGX) upgraded to Buy from Hold at Stifel with analyst Adam Walsh saying yhe expansion of the deal between Protagonist and Janssen for PTG-200 and other IL-23 receptor antagonists brings large pharma validation to the former's oral peptide platform. 4. Penn National (PENN) upgraded to Buy from Neutral at BofA/Merrill with analyst Shaun Kelley stating that its core consumer remains stable and he believes catalysts such as the relaunch of MyChoice and sports betting are being underappreciated by investors. 5. Ferrari (RACE) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Adam Jonas noting the company's better than expected Q1 results and saying he has higher conviction in the company's strategy. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

ISRG

Intuitive Surgical

$536.44

13.25 (2.53%)

17:38
07/18/19
07/18
17:38
07/18/19
17:38
Hot Stocks
Intuitive Surgical falls after Q2 report, despite earnings beat »

Shares of Intuitive are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Aug

  • 09

    Sep

GLD

SPDR Gold Shares

$136.44

1.85 (1.37%)

17:33
07/18/19
07/18
17:33
07/18/19
17:33
Hot Stocks
SPDR Gold Shares holdings rise to 814.62MT from 803.18MT »

This is the highest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAL

Western Alliance

$44.45

0.74 (1.69%)

17:29
07/18/19
07/18
17:29
07/18/19
17:29
Earnings
Western Alliance reports Q2 EPS 1.19, consensus $1.16 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 06

    Aug

ENB

Enbridge

$36.29

0.17 (0.47%)

17:22
07/18/19
07/18
17:22
07/18/19
17:22
Initiation
Enbridge initiated at Goldman Sachs »

Enbridge initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

SEAS

SeaWorld

$33.81

0.38 (1.14%)

17:21
07/18/19
07/18
17:21
07/18/19
17:21
Periodicals
Travel company Virgin Holidays will end selling tickets to SeaWorld, Sun says »

According to the Sun, …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

IEP

Icahn Enterprises

$75.06

-0.14 (-0.19%)

17:20
07/18/19
07/18
17:20
07/18/19
17:20
Syndicate
Breaking Syndicate news story on Icahn Enterprises »

Icahn Enterprises files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RICK

RCI Hospitality

$16.80

0.08 (0.48%)

17:13
07/18/19
07/18
17:13
07/18/19
17:13
Hot Stocks
RCI Hospitality auditor BDO resigns, company files Nasdaq compliance plan »

RCI Hospitality announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BEDU

Bright Scholar

$9.60

-0.06 (-0.62%)

17:03
07/18/19
07/18
17:03
07/18/19
17:03
Earnings
Bright Scholar reports Q3 EPS 16c, two estimates 21c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

ISRG

Intuitive Surgical

$536.44

13.25 (2.53%)

17:03
07/18/19
07/18
17:03
07/18/19
17:03
Hot Stocks
Intuitive Surgical refines FY19 procedure growth view to 16%-17% from 15%-17% »

Still sees FY19 tax rate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Aug

  • 09

    Sep

CUB

Cubic

$66.59

-0.37 (-0.55%)

17:01
07/18/19
07/18
17:01
07/18/19
17:01
Hot Stocks
Cubic receives extension on simulation services contract in Australia »

Cubic Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLRO

ClearOne

$2.27

(0.00%)

16:52
07/18/19
07/18
16:52
07/18/19
16:52
Hot Stocks
Shure files patent infringement suit against ClearOne »

Shure announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISRG

Intuitive Surgical

$536.44

13.25 (2.53%)

16:50
07/18/19
07/18
16:50
07/18/19
16:50
Hot Stocks
Intuitive Surgical says 74% of systems placed in Q2 were da Vinci XIs »

Says team has done a nice…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Aug

  • 09

    Sep

ETN

Eaton

$79.03

-0.36 (-0.45%)

16:49
07/18/19
07/18
16:49
07/18/19
16:49
Hot Stocks
Eaton acquires Innovative Switchgear Solutions »

Eaton announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

ZNGA

Zynga

$6.30

0.07 (1.12%)

16:47
07/18/19
07/18
16:47
07/18/19
16:47
Hot Stocks
Zynga to expand India market with larger space in 'central hub' Bengaluru »

Earlier on Thursday,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 13

    Nov

FNF

Fidelity National

$42.65

-0.045 (-0.11%)

16:43
07/18/19
07/18
16:43
07/18/19
16:43
Recommendations
Fidelity National analyst commentary at Keefe Bruyette »

Fidelity National price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 13

    Nov

AIG

AIG

$55.58

0.2 (0.36%)

16:43
07/18/19
07/18
16:43
07/18/19
16:43
Upgrade
AIG rating change at William Blair »

AIG upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

GOGL

Golden Ocean

$6.63

0.08 (1.22%)

16:42
07/18/19
07/18
16:42
07/18/19
16:42
Syndicate
Breaking Syndicate news story on Golden Ocean »

Golden Ocean files $400M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$361.17

-8.28 (-2.24%)

16:38
07/18/19
07/18
16:38
07/18/19
16:38
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing up over 1% at $366…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

ORCC

Owl Rock

$15.40

(0.00%)

16:38
07/18/19
07/18
16:38
07/18/19
16:38
Initiation
Owl Rock initiated at Compass Point »

Owl Rock initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

FFBC

First Financial Bancorp

$23.90

0.51 (2.18%)

16:37
07/18/19
07/18
16:37
07/18/19
16:37
Hot Stocks
First Financial Bancorp increases dividend 1c to 23c per share »

First Financial Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

KSANF

Kansai Paint

$0.00

(0.00%)

, PPG

PPG

$117.00

0.395 (0.34%)

16:37
07/18/19
07/18
16:37
07/18/19
16:37
Periodicals
Axalta Coating interests rivals PPG and Kansai Paint, Bloomberg reports »

Axalta Coating (AXTA) has…

KSANF

Kansai Paint

$0.00

(0.00%)

PPG

PPG

$117.00

0.395 (0.34%)

AKZOY

AkzoNobel

$0.00

(0.00%)

AXTA

Axalta Coating

$30.40

0.175 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 24

    Jul

  • 25

    Jul

  • 05

    Aug

GBCI

Glacier Bancorp

$38.75

0.12 (0.31%)

16:36
07/18/19
07/18
16:36
07/18/19
16:36
Earnings
Glacier Bancorp reports Q2 EPS 61c, consensus 59c »

Reports Q2 loan loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 19

    Aug

AA

Alcoa

$23.42

0.27 (1.17%)

16:35
07/18/19
07/18
16:35
07/18/19
16:35
Downgrade
Jefferies downgrades Alcoa to Hold, cuts price target to $23 from $29 »

Jefferies analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

BA

Boeing

$361.17

-8.28 (-2.24%)

16:35
07/18/19
07/18
16:35
07/18/19
16:35
Hot Stocks
Boeing says will issue new FY19 guidance at future date »

Boeing states that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

SEM

Select Medical

$15.65

0.105 (0.68%)

16:33
07/18/19
07/18
16:33
07/18/19
16:33
Earnings
Select Medical sees Q2 ops revenue $1.36B-$1.362B, consensus $1.35B »

As previously disclosed,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 14

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.